← FDA Drug Approvals (Drugs@FDA)
OLANZAPINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2023-03-09
Drug application
- FDA Application #
ANDA202889- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- OLANZAPINE
- Generic name
- Olanzapine
- Active ingredients
- OLANZAPINE
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- ZYDUS PHARMS
- First approval
- 2023-03-09
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown